Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Bupropion for attention deficit hyperactivity and comorbid disorders.

Daviss WB, Pan RJ, Perel JM.

Expert Rev Neurother. 2003 Jan;3(1):9-18. doi: 10.1586/14737175.3.1.9.

PMID:
19810843
2.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
3.

Novel treatments for attention-deficit/hyperactivity disorder in children.

Spencer TJ, Biederman J, Wilens TE, Faraone SV.

J Clin Psychiatry. 2002;63 Suppl 12:16-22. Review.

PMID:
12562057
4.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
5.

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.

Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L.

J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):307-14.

PMID:
11288772
6.

Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.

Kunwar A, Dewan M, Faraone SV.

Expert Opin Pharmacother. 2007 Apr;8(5):555-62. Review.

PMID:
17376012
8.

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.

Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J.

Biol Psychiatry. 2003 Jul 1;54(1):9-16.

PMID:
12842303
9.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
10.

Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples.

Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, et al.

Arch Gen Psychiatry. 1992 Sep;49(9):728-38.

PMID:
1514878
11.

Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.

Spencer T, Biederman J, Steingard R, Wilens T.

J Am Acad Child Adolesc Psychiatry. 1993 Jan;32(1):211-4.

PMID:
8428875
12.

Bupropion: a review of its mechanism of antidepressant activity.

Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, et al.

J Clin Psychiatry. 1995 Sep;56(9):395-401. Review.

PMID:
7665537
13.

[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].

Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M.

Neuropsychiatr. 2007;21(3):187-206. Review. German.

PMID:
17915180
14.
15.

An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.

Riggs PD, Leon SL, Mikulich SK, Pottle LC.

J Am Acad Child Adolesc Psychiatry. 1998 Dec;37(12):1271-8.

PMID:
9847499
16.

Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.

Verbeeck W, Tuinier S, Bekkering GE.

Adv Ther. 2009 Feb;26(2):170-84. doi: 10.1007/s12325-009-0008-7. Epub 2009 Feb 23. Review.

PMID:
19238340
17.

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.

Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ, Schumacher E.

J Am Acad Child Adolesc Psychiatry. 1995 May;34(5):649-57.

PMID:
7775360
18.

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.

Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B.

J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):147-58.

PMID:
11211363
19.
20.

Pharmacological treatments of pathological gambling.

Hollander E, Sood E, Pallanti S, Baldini-Rossi N, Baker B.

J Gambl Stud. 2005 Spring;21(1):99-110. Review.

PMID:
15789195
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk